Benzinga · Oct 6, 2026
Wells Fargo Maintains Equal-Weight on Huntsman, Lowers Price Target to $9
Wells Fargo analyst Abigail Eberts maintains Huntsman (NYSE:HUN) with a Equal-Weight and lowers the price target from $11 to $9.
HU
NYSE · HUN
Huntsman Corporation
Basic Materials · Chemicals
$8.77
Down-$0.13 (-1.43%)
Updated Oct 7, 2026, 4:16 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.86B
- P/E ratio
- -5.89
- Dividend yield
- 12.40%
- 52-week range
- $7.30 – $16.09
- Volume
- 2.36M
- Avg. volume
- 5.45M
Price performance · HUN
HUN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
HUN closed at $8.77 after 21 trading sessions, down 10.51% for the selected period.
- Last close
- $8.77
- Period change
- -10.51%
- Period low
- $8.38
- Period high
- $9.80
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $8.77 | $8.82 | $8.639 | $8.77 | 2.36M |
| Oct 5, 2026 | $8.44 | $8.97 | $8.34 | $8.84 | 4.78M |
| Oct 2, 2026 | $8.58 | $8.7473 | $8.495 | $8.53 | 2.84M |
| Oct 1, 2026 | $8.48 | $8.67 | $8.10 | $8.67 | 3.94M |
| Sep 30, 2026 | $8.34 | $8.485 | $8.33 | $8.40 | 2.06M |
| Sep 29, 2026 | $8.59 | $8.695 | $8.30 | $8.38 | 2.64M |
| Sep 28, 2026 | $8.84 | $8.88 | $8.63 | $8.63 | 2.27M |
| Sep 25, 2026 | $8.76 | $8.92 | $8.7022 | $8.90 | 1.71M |
| Sep 24, 2026 | $9.03 | $9.12 | $8.74 | $8.79 | 2.07M |
| Sep 23, 2026 | $9.26 | $9.28 | $9.04 | $9.10 | 1.59M |
| Sep 22, 2026 | $8.94 | $9.195 | $8.89 | $9.05 | 1.85M |
| Sep 21, 2026 | $9.09 | $9.10 | $8.77 | $8.86 | 2.97M |
| Sep 18, 2026 | $9.21 | $9.21 | $8.945 | $9.09 | 3.95M |
| Sep 17, 2026 | $9.29 | $9.31 | $9.08 | $9.12 | 4.27M |
| Sep 16, 2026 | $9.25 | $9.395 | $9.065 | $9.19 | 4.01M |
| Sep 15, 2026 | $9.15 | $9.33 | $9.085 | $9.22 | 4.17M |
| Sep 14, 2026 | $9.51 | $9.58 | $9.29 | $9.30 | 2.09M |
| Sep 11, 2026 | $9.68 | $9.75 | $9.48 | $9.54 | 1.64M |
| Sep 10, 2026 | $9.51 | $9.735 | $9.465 | $9.53 | 2.23M |
| Sep 9, 2026 | $9.89 | $9.99 | $9.55 | $9.58 | 2.07M |
| Sep 8, 2026 | $9.76 | $9.91 | $9.545 | $9.80 | 2.15M |
Latest HUN news
The latest Smart Investors Daily articles mentioning HUN.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HUN research
Overview
Company profile and research snapshot.
Company profile
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $9.38
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 5, 2026 | UBS | Neutral | — |
| Oct 2, 2026 | Jefferies | Buy | — |
| Sep 30, 2026 | Citigroup | Neutral | — |
| Sep 15, 2026 | Citigroup | Neutral | — |
| Sep 11, 2026 | Keybanc | Overweight | — |
News briefing
Generated Oct 7, 2026, 5:21 PM
Why Is HUN Down Today?
Huntsman Corporation shares declined 1.43% as major financial institutions Wells Fargo and UBS both lowered their price targets to $9, signaling reduced confidence in near-term performance. The coordinated analyst downgrades reflect growing uncertainty around demand dynamics and margin sustainability in the specialty chemicals sector.
Bottom line: Huntsman faces headwinds from coordinated analyst downgrades reflecting concerns about demand and margins in the specialty chemicals space. With both major banks targeting $9 and maintaining neutral stances, the stock appears to be repricing lower amid uncertainty, though the neutral ratings suggest limited further downside without new negative catalysts. Investors should monitor quarterly earnings for signs of margin stabilization and demand trends before considering entry points.
Benzinga · Oct 5, 2026
UBS Maintains Neutral on Huntsman, Lowers Price Target to $9
UBS analyst Joshua Spector maintains Huntsman (NYSE:HUN) with a Neutral and lowers the price target from $10 to $9.
Yahoo · Oct 5, 2026
Huntsman (HUN) Stock Sees Fair Value Cut As Analysts Split On Demand And Margins
Huntsman is back in focus as analysts cut their fair value estimate from about US$11.82 to roughly US$10.85, an adjustment that frames the latest round of price target changes. The move reflects a split view in recent research, with more optimistic analysts pointing to areas of resilience and self help, while more cautious voices highlight softer demand and questions around what P/E investors will accept. As you read on, you will see how to track this evolving Huntsman story and what to watch...
Benzinga · Oct 2, 2026
Jefferies Maintains Buy on Huntsman, Lowers Price Target to $11
Jefferies analyst Laurence Alexander maintains Huntsman (NYSE:HUN) with a Buy and lowers the price target from $16 to $11.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
